Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans

ConclusionsThe results showed geometric mean ratios and 90% CIs for bothCmax and AUC0 –∞ for ulotaront were well within typical bioequivalence criteria of 80 –125% for both the BE and FE studies, thereby confirming the bioequivalence of the two dosage forms and no significant food effect.
Source: Neurology and Therapy - Category: Neurology Source Type: research